(SeaPRwire) –   MONTRÉAL, March 25, 2026 – Mercanto Holdings Inc. (TSXV: MUSH) (“Mercanto” or the “Company”) today announced its financial results for the second quarter of fiscal 2026. The Company’s unaudited consolidated financial statements for the period ended January 31, 2026, and the related management’s discussion and analysis (“MD&A”), can be found on the Company’s SEDAR+ profile.

Q2 2026 Financial Highlights

• Revenue totaled $2,076,820, versus $1,003,116 in the year-ago period (+107% YoY);
• Gross profit reached $464,845, up from $196,413 in the prior-year quarter (+137% YoY);
• EBITDA came in at $252,233, compared to a loss of $(96,038) in the year-ago period (improvement of $348,271 to positive EBITDA);
• Net income was $177,785, versus a net loss of $(109,215) in the prior-year period (improvement of $287,000);
• As of the date of this release, the Company is up to date on all cannabis excise tax obligations, with all owed amounts paid in full and on schedule;
• The Company holds no long-term debt other than lease liabilities;
• As of this release, the Company has 51,674,683 common shares outstanding, reflecting minimal dilution since its late 2021 IPO.

Commercial Update

Alongside its financial results, Mercanto is sharing an update on product initiatives supporting its Québec market strategy.

The Company plans to launch a new 10 mg CBD capsule format (30 capsules per container) in August 2026. The product will be sold in stores alongside Mercanto’s existing 50 mg CBD capsules, expanding the Company’s presence in the CBD capsule category and broadening its retail offering. Management views the lower-dose format as complementary to the existing higher-dose capsules and designed to target a different consumer segment rather than replace current products.

Mercanto already sells 50 mg and 100 mg CBD capsules online via the Québec government’s cannabis e-commerce platform. By August 2026, the Company expects its full four-SKU CBD capsule assortment to be available online, which includes:

• 10 mg CBD capsules
• 25 mg CBD capsules
• 50 mg CBD capsules
• 100 mg CBD capsules

While the complete lineup will be available online, category sales remain primarily driven by retail distribution. Adding the 10 mg CBD capsules to in-store shelves expands Mercanto’s retail lineup and is projected to contribute incrementally to the Company’s CBD category revenue.

Mercanto is also gearing up to launch an infused pre-roll product in June 2026, enhancing its presence in the infused segment—one of the fastest-growing derivative categories in Québec.

About Mercanto Holdings Inc.

Mercanto Holdings Inc. is a cannabis company focused on the Québec market, with a strategy centered on developing, launching and commercializing cannabis products in categories where it believes it can build a differentiated position and drive profitable growth.

For additional information, please refer to the Company’s public filings on SEDAR+.

Forward-Looking Information

This news release contains “forward-looking information” as defined under applicable Canadian securities legislation. Forward-looking information in this release includes, without limitation, statements related to: the anticipated timing of the Company’s 10 mg CBD capsule and infused pre-roll launches; the expected availability of its CBD capsule formats online and in stores; the projected revenue contribution from new products; the Company’s expected position in Québec’s CBD capsule category; and its business strategy, growth plans and commercial outlook.

Forward-looking information is based on several assumptions, including but not limited to continued demand for the Company’s products, successful product launches, uninterrupted manufacturing and supply chains, the timing and outcome of provincial listing and distribution processes, and general economic and regulatory conditions. Forward-looking information is subject to known and unknown risks, uncertainties and other factors—many beyond the Company’s control—that may cause actual results, performance or achievements to differ materially from those implied or expressed by such information. These factors include, without limitation, risks related to product launch delays, changes in provincial purchasing decisions, shifts in consumer preferences, pricing pressure, competitive developments, supply disruptions, regulatory changes and other risks outlined in the Company’s continuous disclosure filings.

Readers are advised not to place undue reliance on forward-looking information. While the Company believes the assumptions and expectations in this information are reasonable, there is no guarantee it will prove accurate. The Company undertakes no obligation to update or revise any forward-looking information—whether due to new information, future events or other reasons—except as required by law.

SOURCE Mercanto Holdings Inc.